-transparent.png){kind=logo}
We have synthesized several 1alpha,25-dihydroxyvitamin D [1alpha,25(OH)2D] derivatives and evaluated their biological activity in terms of their binding affinity for the vitamin D receptor (VDR) and vitamin D-binding protein (DBP), antiproliferative or differentiation-inducing effects on human promyelocytic leukemic HL-60 cells, and transcriptional activity on a rat 25-hydroxyvitamin D3-24-hydroxylase gene promoter, including two vitamin D-responsive elements (VDREs), and human osteocalcin gene promoter, including a VDRE in transfected human osteosarcoma MG-63 cells. Furthermore, human VDR- or retinoic acid X receptor alpha (RXR alpha)-mediated luciferase activities of the derivatives were also measured by a one-hybrid system in human epitheloid carcinoma, cervix HeLa cells and African green monkey kidney CV-1 cells. Binding affinity for VDR, bone-resorbing activity, antiproliferative and cell-differentiating effects, transactivation potencies on target genes and VDR- or RXR alpha-mediated gene regulations of 1alpha,25(OH)2D2 and 1alpha,25(OH)2D4 were almost comparable to the effects of 1alpha,25(OH)2D3 while 24-epi-1alpha,25(OH)2D2 and 1alpha,25(OH)2D7 were much less active than 1alpha,25(OH)2D3 in these respects. This is the first report concerning biological assessment of 1alpha,25(OH)2D2, 1alpha,25(OH)2D3, 1alpha,25(OH)2D4, 24-epi-1alpha,25(OH)2D2 and 1alpha,25(OH)2D7 at the molecular level, especially with regards to the structural differences at the 24R- or 24S-methyl group and a double bond between carbons 22 and 23 in the side chain of 1alpha,25(OH)2D derivatives.
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
April 1988,
The American journal of physiology,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
November 1995,
Chemical & pharmaceutical bulletin,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
June 1978,
The Journal of biological chemistry,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
February 2000,
Biological & pharmaceutical bulletin,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
February 2006,
Biochimica et biophysica acta,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
August 1997,
Biochemistry,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
April 1999,
FEBS letters,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
January 1974,
Vitamins and hormones,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
January 1995,
Calcified tissue international,
N Tsugawa, and
K Nakagawa, and
Y Kawamoto, and
Y Tachibana, and
T Hayashi, and
K Ozono, and
T Okano
March 2007,
Journal of medicinal chemistry,
